New York, NY, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Interventional Oncology Market By Product (Embolization Devices, Ablation Devices, and Support Devices), By Cancer Type (Kidney, Lung, Breast, Liver, Bone Metastasis, and Others), and By Procedure (Thermal Ablation, Non-Thermal Ablation, Transcatheter Arterial Chemoembolization, Transcatheter Arterial Radioembolization, and Transcatheter Arterial Embolization): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025”. According to the report, the global interventional oncology market was USD 1,885 million in 2018 and is expected to generate around USD 3,145 million by 2025, at a CAGR of around 7.6% between 2019 and 2025.
Interventional oncology is a field of interventional radiology that deals with the treatment and diagnosis of primary or metastatic cancers. Escalating cancer patients, increasing elderly population, and rising cancer risk among youth due to unhealthy habits like smoking, chewing tobacco, and alcohol will drive the interventional oncology market in the future. A significant rise in disposable income, increase in cancer awareness, and high adoption of technological advancements are expected to create additional growth opportunities for the interventional oncology market in the years ahead.
Browse through 54 Tables & 31 Figures spread over 150 Pages and in-depth TOC on “Global Interventional Oncology Market: By Product Type, Applications, Industry Size, Share, Growth, Segments, Analysis and Forecast, 2018–2025”.
Request Free Sample Report of Global Interventional Oncology Market @ https://www.zionmarketresearch.com/sample/interventional-oncology-market
On the basis of product, the market includes embolization devices (radioembolic and non-radioactive agents), ablation devices (cryoablation devices, radiofrequency ablation devices, microwave ablation devices, and others), and support devices (microcatheters and guidewires). The embolization segment dominated the market in 2018, due to the growing need for minimally invasive procedures for cancer treatment, increasing adoption of embolization procedures by hospitals and ASCs, and substantial hike in direct selling of embolization products like Bead Block, DC Bead, and DC Bead M1.
By cancer type, the interventional oncology market includes kidney, liver, lung, bone metastasis, breast, and other cancers. Lung cancer dominated the market by generating the highest revenue in 2018, as a large part of the global population regularly smokes tobacco, and increased exposure to naturally occurring radioactive gases, industrial or chemical carcinogens, air pollution, and pre-existing lung diseases like tuberculosis.
Request for PDF Brochure of This Report: https://www.zionmarketresearch.com/requestbrochure/interventional-oncology-market
Based on the procedure, the market comprises thermal tumor ablation, non-thermal tumor ablation, transcatheter arterial chemoembolization, transcatheter arterial embolization, and transcatheter arterial radioembolization. Thermal tumor ablation dominated the market in 2018, due to its better ability to penetrate in tumors and precise treatment capabilities in non-surgical candidates. Additionally, increasing healthcare infrastructural developments, rising healthcare expenditure, and flourishing private healthcare facilities are also fuelling this segment’s growth.
North America dominated the interventional oncology market in 2018, due to the considerably high number of cancer surgeries due to changing lifestyle like smoking, chewing tobacco, and alcohol consumption, growing prevalence of hospitals with innovative infrastructures and equipment, presence of highly advanced technology, and rising consumable disposable income. Moreover increasing aging population base and promising healthcare schemes listed by government agencies are further propelling this regional market. The North American market is also growing due to the rise in both public and private funding through various institutions and reduction in the high risk and lesser pain post surgeries. Additionally, the growing number of training institutes for interventional oncology and constantly innovative treatment procedures for cancer will boost the market in the future. In 2018, about 1.7 million new cancer cases were diagnosed and nearly around 6.5 lakh people died in the same year in the U.S.
Browse the full “Interventional Oncology Market By Product (Embolization Devices, Ablation Devices, and Support Devices), By Cancer Type (Kidney, Lung, Breast, Liver, Bone Metastasis, and Others), and By Procedure (Thermal Ablation, Non-Thermal Ablation, Transcatheter Arterial Chemoembolization, Transcatheter Arterial Radioembolization, and Transcatheter Arterial Embolization): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025” Report at https://www.zionmarketresearch.com/report/interventional-oncology-market
Europe acquired the second-largest share in 2018, due to the growing cancer occurrences among senior citizens. This could be linked to low immune systems and aging that geriatric population is more prone to various cancers like lung, bone, liver, pancreatic, prostate cancer, etc. The UK, France, and Germany have huge market, owing to the increasing disposable income, continuously developing healthcare infrastructure, improvements in technology, and rising cancer awareness. Germany and France along with Italy will be dominating the interventional oncology market in Europe.
The Asia Pacific interventional oncology market is expected to record the highest CAGR in the upcoming years, owing to increasing smoking and consumption of adulterated food, rising investments by companies, growing number of government initiatives to treat various cancer types, escalating geriatric population base, and consistent technological advancements. A growing number of hospitals and several opportunities in untapped countries are also contributing to the interventional oncology market in the Asia Pacific.
Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/interventional-oncology-market
The Middle East and Africa and Latin America are forecasted to grow steadily, owing to developing healthcare infrastructure, increasing cancer awareness, and growing government investments for cancer treatment.
Some major players involved in the interventional oncology market are Boston Scientific, Terumo Corporation, Medtronic, BTG, Ethicon, AngioDynamics, Merit Medical Systems, Sirtex Medical, Eckert & Ziegler, BEBIG, Siemens Healthineers, Varian Medical Systems, and HealthTronics.
Request customized copy of report @ https://www.zionmarketresearch.com/custom/4093
This report segments the global interventional oncology market into:
Global Interventional Oncology Market: Product Analysis
- Embolization Devices
- Radioembolic Agents
- Non-Radioactive Agents
- Ablation Devices
- Radiofrequency Ablation Devices
- Microwave Ablation Devices
- Cryoablation Devices
- Others
- Support Devices
- Guidewires
- Microcatheter
Global Interventional Oncology Market: Cancer Type Analysis
- Kidney Cancer
- Lung Cancer
- Breast Cancer
- Liver Cancer
- Bone Metastasis Cancer
- Others
Global Interventional Oncology Market: Procedure Analysis
- Thermal Tumor Ablation
- Non-Thermal Tumor Ablation
- Transcatheter Arterial Chemoembolization
- Transcatheter Arterial Radioembolization
- Transcatheter Arterial Embolization
Global Interventional Oncology Market: Regional Analysis
- North America
- The U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- The Middle East and Africa
Related Reports:
- Virtual Reality In Healthcare Market: https://www.zionmarketresearch.com/report/virtual-reality-in-healthcare-market
- Medical Laser Systems Market: https://www.zionmarketresearch.com/report/medical-laser-systems-market
- Lung Cancer Therapeutics Market: https://www.zionmarketresearch.com/report/lung-cancer-therapeutics-market
- Precision Medicine Market: https://www.zionmarketresearch.com/report/precision-medicine-market
- Telemedicine Market: https://www.zionmarketresearch.com/report/telemedicine-market
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research
Contact Us:
Joel John
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com
Blog: http://newszmr.com